Conavi Medical Corp. CNVI.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 93.90K | 94.80K | 156.40K | 266.50K | 45.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 93.90K | 94.80K | 156.40K | 266.50K | 45.50K |
| Cost of Revenue | -- | -- | -- | 24.00K | 700.00 |
| Gross Profit | 93.90K | 94.80K | 156.40K | 242.50K | 44.80K |
| SG&A Expenses | 1.34M | 1.59M | 1.75M | 1.18M | 925.10K |
| Depreciation & Amortization | 200.80K | 131.90K | 133.40K | 145.20K | 146.70K |
| Other Operating Expenses | -- | -24.80K | 255.40K | 11.60K | -- |
| Total Operating Expenses | 4.71M | 3.43M | 3.85M | 3.96M | 3.39M |
| Operating Income | -4.62M | -3.34M | -3.69M | -3.69M | -3.35M |
| Income Before Tax | -4.57M | -3.49M | -1.94M | -4.93M | -2.57M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.57M | -3.49M | -1.94M | -4.93M | -2.57M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.57M | -3.49M | -1.94M | -4.93M | -2.57M |
| EBIT | -4.62M | -3.34M | -3.69M | -3.69M | -3.35M |
| EBITDA | -4.47M | -3.26M | -3.61M | -3.60M | -3.25M |
| EPS Basic | -0.04 | -0.03 | -0.03 | -0.06 | -0.04 |
| Normalized Basic EPS | -0.03 | -0.02 | -0.02 | -0.04 | -0.02 |
| EPS Diluted | -0.04 | -0.03 | -0.03 | -0.06 | -0.04 |
| Normalized Diluted EPS | -0.03 | -0.02 | -0.02 | -0.04 | -0.02 |
| Average Basic Shares Outstanding | 103.49M | 99.89M | 76.75M | 77.19M | 68.54M |
| Average Diluted Shares Outstanding | 103.49M | 99.89M | 76.75M | 77.19M | 68.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |